Yi Tu

2.0k total citations
76 papers, 1.1k citations indexed

About

Yi Tu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yi Tu has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Yi Tu's work include Radiomics and Machine Learning in Medical Imaging (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Autophagy in Disease and Therapy (6 papers). Yi Tu is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Autophagy in Disease and Therapy (6 papers). Yi Tu collaborates with scholars based in China, United States and Singapore. Yi Tu's co-authors include Feng Yao, Xiaoli Yao, Yulin Xu, Xinghua Zhang, Shengrong Sun, Dawei Cheng, Liqing Zhang, Chenyu Wang, Huaxiong Wang and Guoai Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yi Tu

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Tu China 18 397 231 175 118 107 76 1.1k
Xinli Huang China 26 724 1.8× 458 2.0× 135 0.8× 83 0.7× 84 0.8× 101 1.7k
Xinyi Zhang China 19 434 1.1× 128 0.6× 276 1.6× 88 0.7× 47 0.4× 110 1.4k
Kangjie Chen China 21 379 1.0× 240 1.0× 365 2.1× 112 0.9× 110 1.0× 44 1.2k
Dacheng He China 23 782 2.0× 181 0.8× 237 1.4× 85 0.7× 33 0.3× 60 1.4k
Zongyuan Yang China 21 673 1.7× 356 1.5× 276 1.6× 71 0.6× 31 0.3× 70 1.4k
Hongyu Zhu China 18 310 0.8× 176 0.8× 88 0.5× 156 1.3× 73 0.7× 55 1.1k
Rui Hou China 22 357 0.9× 159 0.7× 109 0.6× 174 1.5× 25 0.2× 115 1.2k
Pengfei Liu China 16 361 0.9× 189 0.8× 106 0.6× 92 0.8× 57 0.5× 77 831
Zhuqing Jia China 25 879 2.2× 296 1.3× 123 0.7× 303 2.6× 57 0.5× 68 1.8k

Countries citing papers authored by Yi Tu

Since Specialization
Citations

This map shows the geographic impact of Yi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tu more than expected).

Fields of papers citing papers by Yi Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tu. The network helps show where Yi Tu may publish in the future.

Co-authorship network of co-authors of Yi Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Tu. A scholar is included among the top collaborators of Yi Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Tu. Yi Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Li, Xiang Guo, Hui Zhang, et al.. (2025). Cisplatin-induced WWP1-eccDNA expression contributes to ovarian cancer resistance. Advances in Clinical and Experimental Medicine. 35(2). 279–290. 1 indexed citations
2.
Tu, Yi, Ziming Zhang, Jun Zou, et al.. (2025). Architecture-engineered Fe₃O₄-MnO₂ composite for peroxydisulfate activation: Visible light-enhanced redox cycling mechanism. Journal of Water Process Engineering. 79. 108963–108963.
3.
Xia, Siyu, et al.. (2025). Identification and validation of NETs-related biomarkers in active tuberculosis through bioinformatics analysis and machine learning algorithms. Frontiers in Immunology. 16. 1599667–1599667. 2 indexed citations
4.
Wu, Jiong, Jian Zhang, Man Li, et al.. (2024). A phase Ib study of PI3Kα inhibitor risovalisib mesylate in combination with fulvestrant in patients with PIK3CA-mutated, HR+/HER2- advanced breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1047–1047. 1 indexed citations
5.
6.
Wu, Qi, Xin Yu, Juanjuan Li, Shengrong Sun, & Yi Tu. (2021). Metabolic regulation in the immune response to cancer. Cancer Communications. 41(8). 661–694. 37 indexed citations
7.
Chen, Changyu, Qiang Zheng, Wenzheng Chen, et al.. (2021). The RNA-Binding Protein NELFE Promotes Gastric Cancer Growth and Metastasis Through E2F2. Frontiers in Oncology. 11. 677111–677111. 11 indexed citations
8.
Liu, Jianhua, Jingping Yuan, Juan Wu, et al.. (2021). Intraductal administration of N-methyl-N-nitrosourea as a novel rodent mammary tumor model. Annals of Translational Medicine. 9(7). 576–576. 8 indexed citations
9.
Liu, Hanqing, Ling Zhan, Liantao Guo, et al.. (2021). More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study. International Journal of General Medicine. Volume 14. 7197–7206. 17 indexed citations
10.
Yao, Xiaoli, et al.. (2020). Endoplasmic reticulum stress confers 5-fluorouracil resistance in breast cancer cell via the GRP78/OCT4/lncRNA MIAT/AKT pathway.. PubMed Central. 10(3). 838–855. 49 indexed citations
11.
Tu, Yi, Li Niu, Weijie Zhao, Dawei Cheng, & Liqing Zhang. (2020). Image Cropping with Composition and Saliency Aware Aesthetic Score Map. Proceedings of the AAAI Conference on Artificial Intelligence. 34(7). 12104–12111. 35 indexed citations
12.
Wang, Yuan, Shan Zhu, Wen Wei, et al.. (2020). Interleukin-6 knockout reverses macrophage differentiation imbalance and alleviates cardiac dysfunction in aging mice. Aging. 12(20). 20184–20197. 12 indexed citations
13.
Tu, Yi, Li Niu, Dawei Cheng, & Liqing Zhang. (2019). ProtoNet: Learning from Web Data with Memory. arXiv (Cornell University). 1 indexed citations
14.
Tu, Yi, et al.. (2019). Learning from Web Data with Memory Module. arXiv (Cornell University).
15.
Hong, Le Van, et al.. (2018). Isolated Langerhans cell histiocytosis of the spleen. Medicine. 97(38). e12378–e12378. 4 indexed citations
16.
Yu, Xiaolong, Runsheng Guo, Hucheng Liu, et al.. (2016). Aneurysmal bone cyst secondary to a giant cell tumor of the patella: A case report. Oncology Letters. 11(2). 1481–1485. 9 indexed citations
17.
Chen, Chuang, Jingping Yuan, Wen Wei, et al.. (2014). Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications. International Journal of Nanomedicine. 9. 1039–1039. 13 indexed citations
18.
Gan, Lu, Yi Tu, Jinming Zhang, et al.. (2013). The effect of genome duplication on seed germination and seedling growth of rice under salt stress. Australian Journal of Crop Science. 7(12). 1814–1821. 18 indexed citations
19.
Tu, Yi, et al.. (2013). [Diagnostic implications of atypical squamous cells of unknown significance with abnormal DNA ploidy for early cervical lesions].. PubMed. 42(12). 829–32. 1 indexed citations
20.
Xu, Zhiliang, et al.. (2013). Carbon nanoparticles suspension used in the central group lymph node dissection of papillary thyroid carcinoma. Zhonghua shiyan waike zazhi. 30(10). 2198–2200. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026